Cargando…
Unique depot formed by an oil based vaccine facilitates active antigen uptake and provides effective tumour control
BACKGROUND: Oil emulsions are commonly used as vaccine delivery platforms to facilitate slow release of antigen by forming a depot at the injection site. Antigen is trapped in the aqueous phase and as the emulsion degrades in vivo the antigen is passively released. DepoVax™ is a unique oil based del...
Autores principales: | Brewer, Kimberly D., Weir, Genevieve M., Dude, Iulia, Davis, Christa, Parsons, Cathryn, Penwell, Andrea, Rajagopalan, Rajkannan, Sammatur, Leeladhar, Bowen, Chris V., Stanford, Marianne M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787234/ https://www.ncbi.nlm.nih.gov/pubmed/29374458 http://dx.doi.org/10.1186/s12929-018-0413-9 |
Ejemplares similares
-
Using lymph node swelling as a potential biomarker for successful vaccination
por: Brewer, Kimberly D., et al.
Publicado: (2016) -
Single dose of DPX-rPA, an enhanced-delivery anthrax vaccine formulation, protects against a lethal Bacillusanthracis spore inhalation challenge
por: Weir, Genevieve M., et al.
Publicado: (2019) -
Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platform
por: MacDonald, Lisa D., et al.
Publicado: (2017) -
Using MRI to evaluate and predict therapeutic success from depot-based cancer vaccines
por: DeBay, Drew R, et al.
Publicado: (2015) -
Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients
por: Berinstein, Neil L, et al.
Publicado: (2015)